1Resident, Department of Medicine, Datta Meghe Institute of Medical Sciences, Sawangi, Wardha, Maharashtra, India
2Professor and Unit Head, Department of Medicine, Datta Meghe Institute of Medical Sciences, Sawangi, Wardha, Maharashtra, India
3Assistant Professor, Department of Medicine, Datta Meghe Institute of Medical Sciences, Sawangi, Wardha, Maharashtra, India
4Resident, Department of Medicine, Datta Meghe Institute of Medical Sciences, Sawangi, Wardha, Maharashtra, India
*Corresponding Author Dr. Shilpa Gaidhane, Professor and Unit Head, Department of Medicine, Datta Meghe Institute of Medical Sciences (DU), Sawangi, Wardha-442001, Maharashtra, India, Email: drshilpagaidhane@gmail.com
Online Published on 28 July, 2023.
Pulmonary edema to a lesser extent is one of the common clinical manifestations of drug-induced lung diseases. Clinical features and radiographic appearances are generally indistinguishable from other causes of pulmonary edema. Typical manifestations include dyspnea, chest discomfort, tachypnea, and hypoxemia. Chest radiographs commonly reveal interstitial and alveolar filling infiltrates. Unlike pulmonary edema that is due to congestive heart failure, cardiomegaly and pulmonary vascular redistribution, are generally absent in cases that are drug-induced. Rare cases of drug-induced myocarditis with heart failure and pulmonary edema have been described. Results from laboratory evaluation and respiratory function tests are nonspecific. We present a case of pulmonary oedema which was precipitated after use nonsteroidal anti-inflammatory drugs (NSAID).
